---
created: '2026-02-09T05:54:32.057138Z'
description: An intermediate stage between normal age-related cognitive decline and
  dementia. Represents increased risk for progression to Alzheimer's disease or other
  dementias, but may remain stable or improve.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/condition/mild-cognitive-impairment/
slug: mild-cognitive-impairment
tags:
- condition
- neurodegeneration
- cognition
- aging
- prodromal
templateEngineOverride: njk
title: Mild Cognitive Impairment
type: condition
updated: '2026-02-09T05:54:32.057138Z'
---

{% raw %}
<h1>Mild Cognitive Impairment</h1>
<h2>Overview</h2>
<p>Mild Cognitive Impairment (MCI) is a clinical syndrome characterized by cognitive decline greater than expected for age but not severe enough to meet criteria for dementia. It represents a critical window for early intervention and prevention strategies.</p>
<h2>Subtypes</h2>
<ol>
<li><strong>Amnestic MCI (aMCI)</strong>: Primarily memory impairment; higher risk of progression to Alzheimer's disease</li>
<li><strong>Non-Amnestic MCI</strong>: Impairment in other cognitive domains (attention, language, visuospatial); may progress to other dementias</li>
</ol>
<h2>Diagnostic Criteria (NIA-AA)</h2>
<ol>
<li>Concern about cognitive change from patient, informant, or clinician</li>
<li>Objective evidence of impairment in one or more cognitive domains</li>
<li>Preservation of independence in functional abilities</li>
<li>Not demented</li>
</ol>
<h2>Progression Rates</h2>
<ul>
<li><strong>10-15%</strong> annual conversion to dementia (vs. 1-2% in normal aging)</li>
<li><strong>~30-40%</strong> remain stable over 5 years</li>
<li><strong>~15-20%</strong> may revert to normal cognition</li>
</ul>
<h2>Risk Factors</h2>
<ul>
<li>Age (primary risk factor)</li>
<li>APOE ε4 allele</li>
<li>Cardiovascular risk factors (hypertension, diabetes, dyslipidemia)</li>
<li>Low education/cognitive reserve</li>
<li>Depression</li>
<li>Sleep disorders</li>
</ul>
<!-- NEO4J_CONTENT_START -->
<h2>Relationships</h2>
<h3>Related</h3>
<ul>
<li>← [[Amyloid_PET_Imaging]] (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:44.235597'
source: obsidian
</code></pre>
<ul>
<li>← [[FDG-PET]] (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:44.865410'
source: obsidian
</code></pre>
<ul>
<li>← [[Lumbar_Puncture]] (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:45.028418'
source: obsidian
</code></pre>
<ul>
<li>← [[MRI_Volumetry]] (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:45.199836'
source: obsidian
</code></pre>
<ul>
<li>← [[Neuropsychological_Testing]] (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:45.380650'
source: obsidian
</code></pre>
<ul>
<li>← [[Cognitive_Training]] (intervention)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:47.835016'
source: obsidian
</code></pre>
<ul>
<li>← [[Mediterranean_Diet]] (intervention)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:48.486140'
source: obsidian
</code></pre>
<ul>
<li>← [[Sleep_Optimization]] (intervention)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:48.863953'
source: obsidian
</code></pre>
<ul>
<li>← [[Amyloid-Beta_4240_Ratio]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:09.882854'
source: obsidian
</code></pre>
<ul>
<li>← [[BDNF]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.191066'
source: obsidian
</code></pre>
<ul>
<li>← [[Phospho-Tau]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:15.718126'
source: obsidian
</code></pre>
<ul>
<li>← [[Plasma_Amyloid-Beta_Ratio]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:15.960616'
source: obsidian
</code></pre>
<ul>
<li>← [[Plasma_p-tau217]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:16.234462'
source: obsidian
</code></pre>
<ul>
<li>← [[Alzheimers_Disease]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:23.210589'
source: obsidian
</code></pre>
<ul>
<li>← [[Amyloid_Cascade]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.155642'
source: obsidian
</code></pre>
<ul>
<li>← [[Bacopa_Monnieri]] (supplement)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:35.750324'
source: obsidian
</code></pre>
<ul>
<li>← [[Omega-3_DHA]] (supplement)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:39.685849'
source: obsidian
</code></pre>
<ul>
<li>→ [[Neurofilament_Light_Chain]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Mild_Cognitive_Impairment]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Lewy_Body_Dementia]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Mediterranean_Diet]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[BDNF]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Sleep_Optimization]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Vascular_Dementia]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Phospho-Tau]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Phosphatidylserine]] (supplement)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alzheimers_Disease]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Neurofilament_Light_Chain]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Amyloid-Beta_4240_Ratio]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Total_Tau]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Cognitive_Training]] (intervention)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Sleep_Optimization]] (intervention)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Exercise]] (intervention)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[FDG-PET]] (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Mediterranean_Diet]] (intervention)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Vascular_Dementia]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Lions_Mane]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Omega-3_DHA]] (supplement)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Lewy_Body_Dementia]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Bacopa_Monnieri]] (supplement)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Hippocampal_Volume_MRI]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:33.408670'
source: obsidian
</code></pre>
<ul>
<li>→ [[Lumbar_Puncture]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[MRI_Volumetry]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Amyloid_Cascade]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Plasma_Amyloid-Beta_Ratio]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Amyloid_PET_Imaging]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Omega-3_DHA]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Plasma_p-tau217]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Hippocampal_Volume_MRI]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Bacopa_Monnieri]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Cognitive_Training]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Total_Tau]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alzheimers_Disease]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Neuropsychological_Testing]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Amyloid-Beta_4240_Ratio]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Lions_Mane]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:46.716462'
source: obsidian
</code></pre>
<ul>
<li>→ [[Mild_Cognitive_Impairment]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:03:48.937777'
source: obsidian
</code></pre>
<!-- NEO4J_CONTENT_END -->
<h2>Relationships</h2>
<h3>Biomarkers for Progression Risk</h3>
<ul>
<li>← [[Amyloid-Beta 42/40 Ratio]] (biomarker) - <em>CSF or PET; indicates amyloid pathology</em></li>
<li>← [[Phospho-Tau]] (biomarker) - <em>Indicates tau pathology and higher conversion risk</em></li>
<li>← [[Total Tau]] (biomarker) - <em>Marker of neurodegeneration</em></li>
<li>← [[Neurofilament Light Chain]] (biomarker) - <em>Predicts faster decline</em></li>
<li>← [[Hippocampal Volume MRI]] (examination) - <em>Structural neuroimaging</em></li>
<li>← [[FDG-PET]] (examination) - <em>Metabolic imaging</em></li>
</ul>
<h3>Progression Conditions</h3>
<ul>
<li>→ [[Alzheimer's Disease]] (condition) - <em>Most common progression path</em></li>
<li>→ [[Vascular Dementia]] (condition) - <em>Alternative progression</em></li>
<li>→ [[Lewy Body Dementia]] (condition) - <em>Alternative progression</em></li>
</ul>
<h3>Preventive Interventions</h3>
<ul>
<li>← [[Cognitive Training]] (intervention) - <em>May slow progression</em></li>
<li>← [[Exercise]] (intervention) - <em>Cardiovascular and neuroprotective</em></li>
<li>← [[Mediterranean Diet]] (intervention) - <em>Dietary pattern</em></li>
<li>← [[Sleep Optimization]] (intervention) - <em>Glymphatic clearance</em></li>
</ul>
<h3>Neuroprotective Supplements</h3>
<ul>
<li>← [[Omega-3 DHA]] (supplement) - <em>Brain structure support</em></li>
<li>← [[Bacopa Monnieri]] (supplement) - <em>Memory enhancement</em></li>
<li>← [[Lion's Mane]] (supplement) - <em>NGF stimulation</em></li>
<li>← [[Phosphatidylserine]] (supplement) - <em>Membrane support</em></li>
</ul>
<h2>References</h2>
<ol>
<li><strong>Criteria</strong>: Albert, M.S., et al. (2011). &quot;The diagnosis of mild cognitive impairment.&quot; <em>Alzheimer's &amp; Dementia</em>.</li>
<li><strong>Biomarkers</strong>: Jack, C.R., et al. (2018). &quot;NIA-AA Research Framework.&quot; <em>Alzheimer's &amp; Dementia</em>.</li>
</ol>

{% endraw %}